1. Tsuchiya M, Ito G, Hama M, Nagata S, Kawamoto A, Suzuki K, Shimizu H, Anzai S, Takahashi J, Kuno R, Takeoka S, Hiraguri Y, Sugihara HY, Mizutani T, Yui S, Oshima S, Tsuchiya K, Watanabe M, Okamoto R. Functional analysis of isoflavones using patient-derived human colonic organoids. Biochem Biophys Res Commun. 2021, 542, 40-47, doi: 10.1016/j.bbrc.2021.01.021.
2. Kuno R, Ito G, Kawamoto A, Hiraguri Y, Sugihara HY, Takeoka S, Nagata S, Takahashi J, Tsuchiya M, Anzai S, Mizutani T, Shimizu H, Yui S, Oshima S, Tsuchiya K, Watanabe M, Okamoto R. Notch and TNF-α signaling promote cytoplasmic accumulation of OLFM4 in intestinal epithelium cells and exhibit a cell protective role in the inflamed mucosa of IBD patients. Biochem Biophys Rep. 2021, 25, 100906-100906, doi: 10.1016/j.bbrep.2020.100906.
3. Watanabe S, Nishimura R, Shirasaki T, Katsukura N, Hibiya S, Kirimura S, Negi M, Okamoto R, Matsumoto Y, Nakamura T, Watanabe M, Tsuchiya K: Schlafen 11 is a novel target for mucosal regeneration in Ulcerative Colitis. J Crohns Colitis., 2021, doi: 10.1093/ecco-jcc/jjab032.
4. Katsukura N, Watanabe S, Shirasaki T, Hibiya S, Kano Y, Akahoshi K, Tanabe M, Kirimura S, Akashi T, Kitagawa M, Okamoto R, Watanabe M, Tsuchiya K. Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasm. Cancer Sci. 2021, 112(2), 932-944, doi: 10.1111/cas.14755.
5. Takenaka K, Ohtsuka K, Fujii T, Oshima S, Okamoto R, Watanabe M. Deep Neural Network Accurately Predicts Prognosis of Ulcerative Colitis Using Endoscopic Images. Gastroenterology. 2021, 160(6), 2175-2177, doi: 10.1053/j.gastro.2021.01.210.
6. Kaneshiro M, Takenaka K, Suzuki K, Fujii T, Hibiya S, Kawamoto A, Motobayashi M, Shimizu H, Nagahori M, Saito E, Okamoto R, Ohtsuka K, Watanabe M. Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission. Aliment Pharmacol Ther. 2021, 53(8), 900-907, doi: 10.1111/apt.16310
7. Hibiya S, Matsuyama Y, Fujii T, Maeyashiki C, Saito E, Ito K, Shimizu H, Kawamoto A, Motobayashi M, Takenaka K, Nagahori M, Kurosaki M, Yauchi T, Ohtsuka K, Fujiwara T, Okamoto R, Watanabe M. 5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis. Aliment Pharmacol Ther. 2021, 53(1), 103-113, doi: 10.1111/apt.16120
8. Tsugawa N, Yamada D, Watabe T, Onizawa M, Wang S, Nemoto Y, Oshima S, Tsubata T, Adachi T, Kawano Y, Watanabe M, Blumberg RS, Okamoto R, Nagaishi T. CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. Biochem Biophys Res Commun. 2021, 535, 99-105, doi: 10.1016/j.bbrc.2020.11.126.
9. Morikawa R, Nemoto Y, Yonemoto Y, Tanaka S, Takei Y, Oshima S, Nagaishi T, Tsuchiya K, Nozaki K, Mizutani T, Nakamura T, Watanabe M, Okamoto R. Intraepithelial Lymphocytes Suppress Intestinal Tumor Growth by Cell-to-Cell Contact via CD103/E-Cadherin Signal. Cell Mol Gastroenterol Hepatol 2021,11(5),1483-1503, doi: 10.1016/j.jcmgh.2021.01.014.
10. Suzuki K, Okamoto R. Fluidigm Based Single-cell Gene Expression Library Preparation from Patient-derived Small Intestinal Organoids. Bio Protoc 2020, 10(19), e3775, doi: 10.1016/j.bbrc.2020.11.126.